The initiative is specifically designed for patients undergoing hospitalization for bone marrow transplant and hematology/oncology services, according to a Nov. 16 news release from BioIntelliSense.
The program will use BioIntelliSense’s BioButton wearable devices, along with algorithm-based data analytics and a clinical intelligence system. The goal is to combine the monitoring of subtle changes in vital sign trends and early signs of potential patient deterioration to provide actionable clinical insights and facilitate proactive interventions based on the gathered data.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.